<s>
Numerous_JJ types_NN2 of_IO fungi_NN2 are_VBR able_JK to_TO infect_VVI the_AT eye_NN1 ,_, including_II Fusarium_NP1 ,_, Aspergillus_NP1 ,_, Curvularia_NP1 ,_, and_CC Candida_NP1 (_( 4_MC )_) ._. 
</s>
<s>
The_AT fungus_NN1 responsible_JJ for_IF the_AT recent_JJ outbreaks_NN2 of_IO keratitis_NN1 (_( infection_NN1 of_IO the_AT cornea_NN1 )_) due_II21 to_II22 ReNu_NP1 MoistureLoc_NP1 use_NN1 is_VBZ thought_VVN to_TO be_VBI Fusarium_NN1 species_NN ._. 
</s>
<s>
There_EX are_VBR multiple_JJ species_NN within_II the_AT genus_NN1 Fusarium_NN1 ,_, with_IW Fusarium_NN1 solani_NN2 being_VBG known_VVN as_II the_AT most_RGT prevalent_JJ and_CC dangerous_JJ variety_NN1 ._. 
</s>
<s>
Fusarium_NN1 is_VBZ commonly_RR found_VVN on_II plants_NN2 or_CC in_II the_AT soil_NN1 in_II warm_JJ ,_, humid_JJ regions_NN2 around_II the_AT world_NN1 ._. 
</s>
<s>
In_II context_NN1 of_IO Fusarium_NP1 keratitis_NN1 ,_, the_AT hyphae_NN2 from_II the_AT fungus_NN1 may_VM protrude_VVI through_II lesions_NN2 in_II the_AT cornea_NN1 to_TO gain_VVI access_NN1 to_II the_AT inside_NN1 of_IO the_AT cornea_NN1 ._. 
</s>
<s>
If_CS it_PPH1 can_VM get_VVI past_II the_AT primary_JJ defenses_NN2 ,_, such_II21 as_II22 the_AT skin_NN1 or_CC other_JJ mucosal_JJ associated_JJ lymphatic_JJ tissue_NN1 (_( SALT_NN1 and_CC MALT_NN1 respectively_RR )_) tissue_NN1 ,_, then_RT it_PPH1 can_VM cause_VVI an_AT1 infection_NN1 ._. 
</s>
<s>
However_RRQV the_AT SALT_NN1 and_CC MALT_NN1 tissues_NN2 are_VBR reasonably_RR effective_JJ at_II keeping_VVG Fusarium_NN1 out_II21 of_II22 the_AT body_NN1 ._. 
</s>
<s>
Lesions_NN2 in_II the_AT cornea_NN1 could_VM be_VBI caused_VVN by_II physical_JJ damage_NN1 (_( e.g._REX ,_, small_JJ particles_NN2 in_II the_AT air_NN1 ,_, plant_NN1 matter_NN1 )_) or_CC by_II improper_JJ care_NN1 for_IF contact_NN1 lenses_NN2 ._. 
</s>
<s>
Treatments_NN2 for_IF fungi_NN2 are_VBR limited_VVN because_CS they_PPHS2 share_VV0 very_RG similar_JJ DNA_NN1 ,_, RNA_NN1 ,_, and_CC protein_NN1 synthesis_NN1 pathways_NN2 to_II humans_NN2 (_( 4_MC )_) ._. 
</s>
<s>
Once_CS the_AT fungus_NN1 gains_NN2 access_VV0 inside_II the_AT cornea_NN1 ,_, it_PPH1 may_VM grow_VVI and_CC infiltrate_VVI other_JJ areas_NN2 of_IO the_AT eye_NN1 ._. 
</s>
<s>
The_AT cornea_NN1 has_VHZ two_MC main_JJ defenses_NN2 against_II pathogens:1_FO )_) Langerhans_NN2 cells_NN2 and_CC 2_MC )_) immunoglobulins_NN2 (_( 1_MC1 )_) ._. 
</s>
<s>
Langerhans_NP1 cells_NN2 are_VBR mainly_RR found_VVN on_II the_AT outer_JJ regions_NN2 of_IO the_AT cornea_NN1 ._. 
</s>
<s>
The_AT langerhans_NN2 cells_NN2 are_VBR used_VVN to_TO phagocytose_VVI recognized_JJ pathogens_NN2 ,_, and_CC then_RT present_VV0 the_AT digested_JJ fragments_NN2 to_II the_AT stroma_NN1 of_IO the_AT cornea_NN1 ._. 
</s>
<s>
They_PPHS2 may_VM also_RR recognize_VVI antibodies_NN2 or_CC complement_NN1 factors_NN2 which_DDQ have_VHI opsonized_VVN an_AT1 antigen_NN1 ,_, flagging_VVG it_PPH1 for_IF phagocytosis_NN1 ._. 
</s>
<s>
In_II the_AT case_NN1 of_IO fungal_JJ infections_NN2 ,_, complement_NN1 factors_NN2 will_VM not_XX work_VVI because_CS the_AT cell_NN1 wall_NN1 protects_VVZ the_AT cell-membrane_NN1 of_IO the_AT fungus_NN1 (_( 1_MC1 )_) ._. 
</s>
<s>
After_CS digestion_NN1 ,_, the_AT expressed_JJ epitopes_NN2 can_VM be_VBI recognized_VVN by_II B-cells_NN2 or_CC T-cells_NN2 with_IW complementary_JJ receptors_NN2 ._. 
</s>
<s>
This_DD1 could_VM trigger_VVI an_AT1 immune_JJ response_NN1 which_DDQ culminates_VVZ in_II inflammation_NN1 of_IO the_AT cornea_NN1 ._. 
</s>
<s>
Inflammation_NN1 triggers_VVZ the_AT recruitment_NN1 of_IO natural_JJ killer_NN1 cells_NN2 (_( NK_NP1 cells_NN2 )_) ,_, leukocytes_NN2 ,_, and_CC other_JJ lymphocytes_NN2 to_II the_AT site_NN1 of_IO infection_NN1 ._. 
</s>
<s>
When_CS the_AT langerhans_NN2 cells_NN2 phagocytose_VV0 an_AT1 antigen_NN1 ,_, they_PPHS2 mature_VV0 into_II dendritic_JJ cells_NN2 by_II traveling_VVG to_II nearby_JJ lymph_NN1 nodes_NN2 ._. 
</s>
<s>
They_PPHS2 then_RT migrate_VV0 to_II the_AT corneal_JJ stroma_NN1 where_CS they_PPHS2 can_VM release_VVI cytokines_NN2 or_CC other_JJ inflammatory_JJ mediators_NN2 ._. 
</s>
<s>
Cytokines_NN2 released_VVN include_VV0 IL-1_MC1 ,_, IL-6_MC ,_, IL-12_MC ,_, and_CC TNF-alpha_NN1 (_( textbook_NN1 )_) ._. 
</s>
<s>
IL-1_MC1 ,_, IL-6_MC ,_, and_CC TNF-alpha_NN1 are_VBR all_DB synergistic_JJ with_IW each_PPX221 other_PPX222 ._. 
</s>
<s>
They_PPHS2 cause_VV0 the_AT release_NN1 of_IO acute_JJ phase_NN1 proteins_NN2 from_II the_AT liver_NN1 ,_, and_CC activate_VV0 T-cells_NN2 ,_, B-cells_NN2 ,_, or_CC inflammatory_JJ cells_NN2 ._. 
</s>
<s>
IL-12_MC functions_NN2 to_TO activate_VVI NK_NP1 cells_NN2 and_CC also_RR causes_VVZ the_AT proliferation_NN1 of_IO TH1-cells_NN2 ._. 
</s>
<s>
This_DD1 will_VM lead_VVI to_II the_AT eventual_JJ increased_JJ production_NN1 of_IO IFN-_NN1 ._. 
</s>
<s>
Taken_VVN together_RL ,_, a_AT1 cell-mediated_JJ response_NN1 seems_VVZ to_TO be_VBI highly_RR favored_VVN ._. 
</s>
<s>
The_AT second_MD defense_NN1 consists_VVZ of_IO the_AT immunoglobulins_NN2 concentrated_VVN in_II the_AT corneal_JJ stroma_NN1 which_DDQ have_VH0 been_VBN secreted_VVN by_II plasma_NN1 B-cells_NN2 ._. 
</s>
<s>
On_II the_AT surface_NN1 of_IO the_AT cornea_NN1 is_VBZ a_AT1 layer_NN1 of_IO mucous_NN1 glycoprotein_NN1 in_II31 association_II32 with_II33 glycocalyx_NN1 ,_, a_AT1 network_NN1 of_IO polysaccharides_NN2 (_( 1_MC1 )_) ._. 
</s>
<s>
Immunoglobulin_NN1 A_ZZ1 (_( IgA_NN1 )_) ,_, a_AT1 major_JJ class_NN1 of_IO antibodies_NN2 associated_VVN with_IW serum_NN1 and_CC bodily_JJ secretions_NN2 ,_, is_VBZ linked_VVN with_IW these_DD2 layers_NN2 of_IO mucous_NN1 glycoproteins_NN2 ._. 
</s>
<s>
IgA_NN1 is_VBZ essential_JJ as_II part_NN1 of_IO the_AT defense_NN1 against_II specific_JJ fungus_NN1 antigens_NN2 ._. 
</s>
<s>
Immunoglobulins_NN2 not_XX only_RR attach_VV0 to_II the_AT surfaces_NN2 of_IO fungi_NN2 marking_VVG them_PPHO2 for_IF extermination_NN1 ,_, but_CCB also_RR neutralize_VV0 dangerous_JJ mycotoxins_NN2 released_VVN by_II the_AT fungi_NN2 ._. 
</s>
<s>
Unique_JJ to_II infections_NN2 involving_VVG Fusarium_NN1 is_VBZ the_AT lack_NN1 of_IO most_DAT granulocytes_NN2 ,_, also_RR known_VVN as_II polymorphonuclear_JJ leukocytes_NN2 ,_, during_II inflammation_NN1 (_( 1_MC1 )_) ._. 
</s>
<s>
This_DD1 class_NN1 of_IO leukocytes_NN2 includes_VVZ the_AT neutrophils_NN2 ,_, eosinophils_NN2 ,_, and_CC basophils_NN2 ._. 
</s>
<s>
These_DD2 cells_NN2 function_VV0 to_TO release_VVI enzymes_NN2 or_CC oxygen_NN1 radicals_NN2 to_TO destroy_VVI foreign_JJ antigen_NN1 ._. 
</s>
<s>
Basophils_NN2 and_CC eosinophils_NN2 secrete_VV0 Type_NN1 II_MC cytokines_NN2 (_( IL-4_MC or_CC IL-5_MC respectively_RR )_) and_CC tend_VV0 to_TO stimulate_VVI humoral_JJ responses_NN2 within_II the_AT body_NN1 (_( textbook_NN1 )_) ._. 
</s>
<s>
Thus_RR ,_, it_PPH1 makes_VVZ sense_NN1 that_CST there_EX is_VBZ an_AT1 absence_NN1 of_IO humoral-mediated_JJ responses_NN2 in_II the_AT body_NN1 ._. 
</s>
<s>
It_PPH1 has_VHZ been_VBN suggested_VVN that_CST these_DD2 leukocytes_NN2 are_VBR kept_VVN away_II21 from_II22 the_AT eye_NN1 as_II a_AT1 defense_NN1 mechanism_NN1 to_TO prevent_VVI hazardous_JJ inflammation_NN1 which_DDQ could_VM damage_VVI the_AT eye_NN1 ._. 
</s>
<s>
The_AT primary_JJ method_NN1 of_IO dealing_VVG with_IW fungal_JJ infections_NN2 happens_VVZ to_TO be_VBI cell-mediated_JJ ._. 
</s>
<s>
Neutrophils_NN2 and_CC monocytes_NN2 are_VBR very_RG effective_JJ against_II the_AT hyphae_NN2 of_IO Fusarium_NP1 (_( 1_MC1 )_) ._. 
</s>
<s>
These_DD2 cells_NN2 migrate_VV0 to_II sites_NN2 of_IO infection_NN1 ,_, and_CC use_VV0 reactive_JJ oxygen_NN1 species_NN or_CC enzymes_NN2 to_TO kill_VVI ingested_JJ organisms_NN2 ._. 
</s>
<s>
They_PPHS2 are_VBR attracted_VVN to_II the_AT sites_NN2 of_IO infection_NN1 by_II the_AT Type_NN1 I_PPIS1 cytokines_VVZ ,_, IFN-_JJ and_CC G-CSF_NP1 ,_, which_DDQ are_VBR secreted_VVN by_II TH1-cells_NN2 or_CC NK_NP1 cells_NN2 and_CC fibroblasts_NN2 or_CC monocytes_NN2 respectively_RR (_( 1_MC1 )_) ._. 
</s>
<s>
These_DD2 two_MC cytokines_VVZ greatly_RR enhance_VV0 the_AT functioning_NN1 of_IO the_AT neutrophils_NN2 and_CC monocytes_NN2 in_II the_AT eye_NN1 ._. 
</s>
<s>
Monocytes_NN2 can_VM also_RR secrete_VVI IL-1_MC1 to_TO stimulate_VVI T-cell_NN1 activation_NN1 and_CC promote_VVI B-cell_JJ clonal_JJ expansion_NN1 and_CC maturation_NN1 ._. 
</s>
<s>
The_AT important_JJ area_NN1 needed_VVN for_IF all_DB of_IO these_DD2 responses_NN2 can_VM be_VBI found_VVN within_II the_AT protective_JJ epithelium_NN1 of_IO the_AT conjunctiva_NN1 ,_, the_AT membrane_NN1 covering_VVG the_AT sclera_NN1 and_CC lining_VVG the_AT inside_NN1 of_IO eyelids_NN2 (_( 12_MC )_) ._. 
</s>
<s>
The_AT conjunctiva_NN1 is_VBZ likely_JJ to_TO become_VVI inflamed_VVN during_II infection_NN1 ._. 
</s>
<s>
Lymphoid_JJ tissue_NN1 can_VM be_VBI found_VVN in_II this_DD1 area_NN1 ,_, and_CC houses_VVZ the_AT colonies_NN2 of_IO B-cells_NN2 and_CC T-cells_NN2 ._. 
</s>
<s>
B-cells_NN2 here_RL undergo_VV0 maturation_NN1 after_II being_VBG exposed_VVN to_II antigen_NN1 presented_VVN by_II langerhans_NN2 cells_NN2 ._. 
</s>
<s>
The_AT B-cells_NN2 then_RT migrate_VV0 to_II nearby_JJ lymph_NN1 nodes_NN2 to_TO proliferate_VVI into_II plasma_NN1 cells_NN2 ._. 
</s>
<s>
The_AT mature_JJ cells_NN2 then_RT return_VV0 to_II the_AT conjunctiva_NN1 or_CC go_VV0 to_II the_AT blood_NN1 marrow_NN1 to_TO produce_VVI antibodies_NN2 ._. 
</s>
<s>
If_CS in_II the_AT eye_NN1 ,_, IgA_NN1 will_VM be_VBI secreted_VVN (_( 4_MC )_) ._. 
</s>
<s>
T-cells_NN2 are_VBR also_RR stimulated_VVN by_II the_AT antigen_NN1 presented_VVN by_II langerhans_NN2 cells_NN2 or_CC B-cells_NN2 (_( via_II MHC_NP1 II_MC )_) ._. 
</s>
<s>
Helper_NN1 T-cells_NN2 similarly_RR migrate_VV0 nearby_JJ lymph_NN1 nodes_NN2 to_TO mature_VVI ,_, and_CC then_RT return_VVI to_II the_AT conjunctiva_NN1 in_BCL21 order_BCL22 to_TO release_VVI cytokines_NN2 to_TO activate_VVI leukocytes_NN2 or_CC provide_VV0 co-stimulation_NN1 for_IF the_AT functioning_NN1 of_IO other_JJ lymphocytes_NN2 ._. 
</s>
<s>
The_AT majority_NN1 of_IO fungal_JJ keratitis_NN1 occurs_VVZ after_II trauma_NN1 to_II the_AT cornea_NN1 ._. 
</s>
<s>
The_AT early_JJ symptoms_NN2 of_IO fungal_JJ keratitis_NN1 are_VBR blurred_VVN vision_NN1 ,_, a_AT1 red_JJ and_CC painful_JJ eye_NN1 that_CST does_VDZ not_XX improve_VVI when_RRQ contact_NN1 lenses_NN2 are_VBR removed_VVN ,_, increased_JJ sensitivity_NN1 to_TO light_VVI ,_, and_CC excessive_JJ tearing_VVG or_CC discharge_NN1 (_( 11_MC )_) ._. 
</s>
<s>
Fungal_JJ keratitis_NN1 is_VBZ recognizable_JJ by_II the_AT presence_NN1 of_IO a_AT1 coarse_JJ granular_JJ infiltration_NN1 of_IO the_AT corneal_JJ epithelium_NN1 and_CC the_AT anterior_JJ stroma_NN1 ._. 
</s>
<s>
The_AT corneal_JJ defect_NN1 usually_RR becomes_VVZ apparent_JJ within_II 24_MC to_II 36_MC h_ZZ1 after_II the_AT trauma_NN1 ._. 
</s>
<s>
There_EX is_VBZ minimal_JJ to_TO absent_VVI host_NN1 cellular_JJ infiltration_NN1 ._. 
</s>
<s>
The_AT absence_NN1 of_IO inflammatory_JJ cells_NN2 is_VBZ likely_RR a_AT1 good_JJ prognostic_JJ finding_NN1 ,_, since_CS products_NN2 of_IO polymorphonuclear_JJ leukocytes_NN2 contribute_VV0 to_II the_AT destruction_NN1 of_IO the_AT cornea_NN1 ._. 
</s>
<s>
It_PPH1 has_VHZ been_VBN contended_VVN that_DD1 eyelid_NN1 lesions_NN2 are_VBR common_JJ in_II patients_NN2 with_IW eye_NN1 infections_NN2 ._. 
</s>
<s>
The_AT eye_NN1 will_VM appear_VVI white_JJ with_IW filamentous_JJ projections_NN2 from_II the_AT cornea_NN1 after_CS about_RG a_AT1 week_NNT1 ._. 
</s>
<s>
Fusarium_NP1 Keratitis_NP1 may_VM completely_RR destroy_VVI an_AT1 eye_NN1 within_II a_AT1 few_DA2 weeks_NNT2 and_CC malignant_JJ glaucoma_NN1 can_VM ensue_VVI ._. 
</s>
<s>
If_CS not_XX treated_VVN after_II 5or_FO 6_MC weeks_NNT2 ,_, blindness_NN1 may_VM result_VVI ._. 
</s>
<s>
A_AT1 systemic_JJ infection_NN1 is_VBZ unlikely_JJ ._. 
</s>
<s>
If_CS the_AT fungus_NN1 does_VDZ get_VVI past_II the_AT eye_NN1 's_GE defense_NN1 system_NN1 and_CC into_II other_JJ tissues_NN2 ,_, it_PPH1 will_VM be_VBI exposed_VVN to_II all_DB of_IO the_AT immune_JJ defenses_NN2 of_IO the_AT body_NN1 ._. 
</s>
<s>
This_DD1 includes_VVZ inflammatory_JJ macrophages_NN2 ,_, granulocytes_NN2 ,_, and_CC humoral_JJ immunity_NN1 ._. 
</s>
<s>
However_RR ,_, this_DD1 can_VM lead_VVI to_II inflammation_NN1 of_IO the_AT tissue_NN1 surrounding_VVG the_AT eye_NN1 ._. 
</s>
<s>
The_AT eye_NN1 will_VM appear_VVI severely_RR red_JJ and_CC tearing_VVG will_VM ensue_VVI to_TO lower_VVI the_AT pH_NN1 of_IO the_AT eye_NN1 and_CC introduce_VV0 lysozyme_NN1 to_II the_AT fungus_NN1 ._. 
</s>
<s>
Fungal_JJ and_CC human_JJ cells_NN2 have_VH0 similar_JJ mechanisms_NN2 for_IF DNA_NN1 ,_, RNA_NN1 and_CC protein_NN1 synthesis_NN1 ._. 
</s>
<s>
This_DD1 greatly_RR limits_VVZ the_AT number_NN1 of_IO potential_JJ antifungal_JJ drug_NN1 targets_NN2 because_CS the_AT vast_JJ majority_NN1 of_IO compounds_NN2 that_CST inhibit_VV0 fungi_NN2 also_RR are_VBR toxic_JJ to_II human_JJ cells_NN2 ._. 
</s>
<s>
Therefore_RR ,_, antifungal_JJ drugs_NN2 tend_VV0 to_TO target_VVI the_AT few_DA2 features_NN2 of_IO fungal_JJ cells_NN2 that_CST differ_VV0 from_II human_JJ cells_NN2 ._. 
</s>
<s>
Most_DAT fungal_JJ cell_NN1 membranes_NN2 contain_VV0 ergosterol_NN1 ,_, rather_II21 than_II22 cholesterol_NN1 ,_, which_DDQ is_VBZ the_AT sterol_NN1 found_VVN in_II human_JJ cell_NN1 membranes_NN2 ._. 
</s>
<s>
Amphotericin_NN1 B_ZZ1 directly_RR binds_VVZ to_TO ergosterol_VVI ,_, whereas_CS the_AT azoles_NN2 (_( e.g._REX ,_, itraconazole_NN1 ,_, fluconazole_NN1 ,_, voriconazole_NN1 ,_, miconazole_NN1 ,_, ketoconazole_NN1 )_) and_CC terbinafine_VV0 target_NN1 ergosterol_NN1 synthesis_NN1 (_( 4_MC )_) ._. 
</s>
<s>
However_RR ,_, the_AT major_JJ distinguishing_JJ feature_NN1 of_IO fungal_JJ cells_NN2 is_VBZ a_AT1 rigid_JJ cell_NN1 wall_NN1 containing_VVG chitin_NN1 ,_, mannans_NN2 and_CC glucans_NN2 (_( the_AT target_NN1 of_IO the_AT echinocandin_NN1 class_NN1 of_IO antifungal_JJ drugs_NN2 )_) ._. 
</s>
<s>
Fluconazole_NN1 is_VBZ an_AT1 oral_JJ anti-fungal_JJ medication_NN1 known_VVN to_TO be_VBI effective_JJ in_II curing_VVG numerous_JJ types_NN2 of_IO fungal_JJ infections_NN2 throughout_II the_AT body_NN1 ._. 
</s>
<s>
It_PPH1 functions_VVZ to_TO block_VVI the_AT pathway_NN1 for_IF sterol_NN1 synthesis_NN1 in_II Fungi_NP1 (_( 3_MC )_) ._. 
</s>
<s>
Clinical_JJ trials_NN2 have_VH0 shown_VVN that_CST it_PPH1 is_VBZ able_JK to_TO fight_VVI fungal_JJ eye_NN1 infections_NN2 like_II Fusarium_NP1 keratitis_NN1 ._. 
</s>
<s>
The_AT active_JJ ingredient_NN1 is_VBZ 2,4-difluoro-_FO ,_, 1-bis(1H-1,2,4-triazol-1-ylmethyl)_FU benzyl_NN1 alcohol_NN1 ._. 
</s>
<s>
Fluconazole_NN1 is_VBZ sold_VVN under_II the_AT name_NN1 Diflucan_NN1 ,_, made_VVN by_II Pfizer_NP1 ._. 
</s>
<s>
One_MC1 dose_NN1 is_VBZ 100mg_NNU ,_, and_CC 30_MC pills_NN2 costs_VVZ $434.98_NNU ._. 
</s>
<s>
Two_MC pills_NN2 are_VBR taken_VVN daily_RR for_IF two_MC weeks_NNT2 ,_, or_CC until_CS symptoms_NN2 cease_VV0 to_TO exist_VVI ._. 
</s>
<s>
Natamycin_NN1 is_VBZ highly_RR effective_JJ at_II fighting_VVG fungal_JJ Keratitus_NN1 ._. 
</s>
<s>
Natamycin_NN1 is_VBZ a_AT1 tetraene_NN1 polyene_NN1 antibiotic_NN1 derived_VVN from_II Streptomyces_NP2 natalensis_NN1 ._. 
</s>
<s>
The_AT mechanism_NN1 of_IO action_NN1 appears_VVZ to_TO be_VBI through_II binding_VVG of_IO the_AT molecule_NN1 to_II the_AT sterol_NN1 moiety_NN1 of_IO the_AT fungal_JJ cell_NN1 membrane_NN1 ._. 
</s>
<s>
The_AT polyenesterol_NN1 complex_NN1 alters_VVZ the_AT permeability_NN1 of_IO the_AT membrane_NN1 to_TO produce_VVI depletion_NN1 of_IO essential_JJ cellular_JJ constituents_NN2 ._. 
</s>
<s>
The_AT active_JJ ingredient_NN1 is_VBZ a_AT1 stereoisomer_JJR of_IO 22-(_( (_( 3-amino-3_MC ,_, 6-dideoxy-(beta)-D-mannopyranosyl_FU )_) oxy_NN1 )_) -1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo&lsqb;22.3.1.0_FU 5,7_MC )_) octacosa-8,14,16,18,20-pentaene-25-carboxylic_FU acid_NN1 (_( 3_MC )_) ._. 
</s>
<s>
The_AT manufacturer_NN1 is_VBZ Alcon_NP1 ,_, and_CC sold_VVN under_II the_AT name_NN1 Natacyn_NP1 ._. 
</s>
<s>
A_ZZ1 15mL_NNU bottle_NN1 costs_VVZ $220_NNU ._. 
</s>
<s>
Natacyn_NP1 is_VBZ administered_VVN is_VBZ through_II the_AT use_NN1 of_IO eyedrops_NN2 ._. 
</s>
<s>
The_AT user_NN1 usually_RR takes_VVZ one_MC1 eyedrop_VV0 every_AT1 4_MC to_II 6_MC hours_NNT2 ,_, though_CS more_RGR serious_JJ infections_NN2 may_VM require_VVI a_AT1 higher_JJR dose_NN1 ._. 
</s>
<s>
Due_II21 to_II22 the_AT economic_JJ restraints_NN2 held_VVN by_II some_DD of_IO the_AT sufferers_NN2 of_IO the_AT Fusarium_NP1 Keratitis_NP1 infection_NN1 ,_, our_APPGE outlook_NN1 would_VM be_VBI that_CST an_AT1 alternative_NN1 more_RGR affordable_JJ means_NN of_IO therapy_NN1 should_VM also_RR be_VBI looked_VVN at_II as_II a_AT1 potential_JJ cure_NN1 ._. 
</s>
<s>
We_PPIS2 recommend_VV0 the_AT product_NN1 Melaleuca_NP1 Alternifolia_JJ or_CC more_RGR commonly_RR known_VVN as_II tea_NN1 tree_NN1 oil_NN1 ._. 
</s>
<s>
It_PPH1 has_VHZ already_RR been_VBN proven_VVN through_II laboratory_NN1 research_NN1 to_TO be_VBI an_AT1 effective_JJ substitute_NN1 from_II conventional_JJ medicine_NN1 in_II treating_VVG fungal_JJ infections_NN2 of_IO the_AT mouth_NN1 and_CC foot_NN1 (_( 8_MC )_) ._. 
</s>
<s>
The_AT active_JJ ingredients_NN2 involved_JJ in_II tea_NN1 tree_NN1 oil_NN1 are_VBR Terpinen-4-ol_NP1 and_CC Cineole_NP1 (_( 8_MC )_) ._. 
</s>
<s>
It_PPH1 is_VBZ mainly_RR produced_VVN in_II Australia_NP1 and_CC marketed_VVN in_II the_AT United_NP1 States_NP1 by_II the_AT company_NN1 Desert_NN1 Essence_NN1 ._. 
</s>
<s>
They_PPHS2 sell_VV0 their_APPGE product_NN1 for_IF the_AT price_NN1 of_IO $19.99_NNU for_IF every_AT1 2_MC fluid_JJ ounces_NNU2 (_( 7_MC )_) ._. 
</s>
<s>
We_PPIS2 propose_VV0 that_CST the_AT initiative_NN1 be_VBI taken_VVN to_TO enhance_VVI the_AT product_NN1 into_II a_AT1 form_NN1 suitable_JJ for_IF application_NN1 to_II the_AT eye_NN1 (_( i.e._REX eye_NN1 drops_VVZ )_) ._. 
</s>
<s>
As_II21 of_II22 now_RT only_RR a_AT1 topical_JJ solution_NN1 is_VBZ available_JJ which_DDQ is_VBZ both_RR used_VVN in_II the_AT diluted_JJ form_NN1 for_IF gargling_VVG in_II the_AT mouth_NN1 ,_, and_CC as_II a_AT1 direct_JJ applicant_NN1 to_II the_AT skin_NN1 ._. 
</s>
<s>
Eye_NN1 drop_NN1 usage_NN1 once_RR every_AT1 4-6_MCMC hours_NNT2 as_CSA has_VHZ been_VBN shown_VVN to_TO be_VBI effective_JJ with_IW Natacyn_NP1 may_VM be_VBI sufficient_JJ ,_, but_CCB if_CS results_NN2 did_VDD not_XX show_VVI then_RT an_AT1 increase_NN1 in_II the_AT frequency_NN1 of_IO application_NN1 could_VM be_VBI imposed_VVN ._. 
</s>
<s>
The_AT ReNu_NP1 MoisturLoc_NP1 product_NN1 may_VM have_VHI been_VBN sterile_JJ when_CS it_PPH1 left_VVD the_AT plant_NN1 in_II Greenville_NP1 ._. 
</s>
<s>
However_RR ,_, the_AT ingredients_NN2 in_II MoisturLoc_NP1 are_VBR different_JJ from_II the_AT other_JJ formulas_NN2 made_VVN by_II Bausch_NP1 ._. 
</s>
<s>
It_PPH1 is_VBZ important_JJ to_TO note_VVI that_DD1 only_JJ ReNU_NP1 MoisturLoc_NP1 is_VBZ related_VVN to_II the_AT greater_JJR chance_NN1 of_IO developing_VVG the_AT Fusarium_NP1 Keratitus_NP1 infection_NN1 ._. 
</s>
<s>
One_MC1 reason_NN1 this_DD1 could_VM be_VBI possible_JJ is_VBZ because_CS the_AT MoisturLoc_NP1 provides_VVZ an_AT1 environment_NN1 where_CS the_AT Fusarium_NN1 can_VM thrive_VVI and_CC reproduce_VVI in_RP ._. 
</s>
<s>
The_AT MoisturLoc_NP1 may_VM be_VBI a_AT1 sort_NN1 of_IO "_" minimal_JJ essential_JJ media_NN "_" for_IF the_AT fungus_NN1 ._. 
</s>
<s>
It_PPH1 is_VBZ already_RR known_VVN that_CST the_AT Fusarium_NP1 did_VDD not_XX come_VVI from_II the_AT factory_NN1 ._. 
</s>
<s>
However_RR ,_, when_CS the_AT user_NN1 puts_VVZ the_AT MoisturLoc_NP1 in_II the_AT contact_NN1 cases_NN2 ,_, Fusarium_NP1 is_VBZ able_JK to_TO grow_VVI on_II the_AT lens_NN1 ._. 
</s>
<s>
The_AT method_NN1 by_II which_DDQ Fusarium_NP1 gets_VVZ access_NN1 to_II the_AT solution_NN1 is_VBZ unknown_JJ ,_, but_CCB since_CS spores_NN2 can_VM be_VBI airborne_JJ it_PPH1 is_VBZ possible_JJ for_IF the_AT fungus_NN1 to_TO randomly_RR land_VVI in_II the_AT solution_NN1 ._. 
</s>
<s>
In_II this_DD1 case_NN1 ,_, the_AT probability_NN1 of_IO contaminating_VVG the_AT solution_NN1 depends_VVZ on_II the_AT user_NN1 ;_; if_CS the_AT user_NN1 keeps_VVZ the_AT solution_NN1 near_II outdoor_JJ areas_NN2 or_CC other_JJ places_NN2 with_IW spores_NN2 ,_, then_RT the_AT likelihood_NN1 of_IO contamination_NN1 increases_NN2 ._. 
</s>
<s>
After_CS the_AT user_NN1 puts_VVZ the_AT infected_JJ contacts_NN2 in_II their_APPGE eyes_NN2 ,_, the_AT fungus_NN1 on_II the_AT lens_NN1 will_VM come_VVI into_II contact_NN1 with_IW the_AT eye_NN1 ._. 
</s>
<s>
The_AT fungus_NN1 is_VBZ then_RT trapped_VVN between_II the_AT eye_NN1 and_CC contact_NN1 lens_NN1 for_IF the_AT entire_JJ day_NNT1 which_DDQ gives_VVZ the_AT Fusarium_NN1 enough_DD time_NNT1 to_TO get_VVI through_II the_AT cornea_NN1 and_CC reproduce_VVI in_II the_AT eye_NN1 ,_, causing_VVG infection_NN1 ._. 
</s>
<s>
Another_DD1 possible_JJ reason_NN1 that_CST the_AT ReNu_NP1 MoistureLoc_NP1 may_VM be_VBI causing_VVG infection_NN1 is_VBZ because_CS a_AT1 chemical_NN1 in_II MoistureLoc_NP1 may_VM be_VBI causing_VVG the_AT defense_NN1 system_NN1 of_IO the_AT eye_NN1 to_II malfunction_NN1 ._. 
</s>
<s>
An_AT1 ingredient_NN1 in_II the_AT solution_NN1 may_VM be_VBI acting_VVG as_II an_AT1 inhibitor_NN1 of_IO a_AT1 defense_NN1 mechanism_NN1 ._. 
</s>
<s>
Normally_RR the_AT eye_NN1 may_VM come_VVI into_II contact_NN1 with_IW Fusarium_NN1 on_II a_AT1 daily_JJ or_CC weekly_JJ basis_NN1 ._. 
</s>
<s>
The_AT lymphoid_JJ tissue_NN1 of_IO the_AT conjunctiva_NN1 is_VBZ usually_RR able_JK to_TO fight_VVI off_II the_AT infection_NN1 under_II normal_JJ conditions_NN2 ._. 
</s>
<s>
However_RR ,_, when_CS a_AT1 patient_NN1 who_PNQS uses_VVZ contacts_NN2 with_IW MoisturLoc_NP1 comes_VVZ into_II contact_NN1 with_IW the_AT eye_NN1 ,_, perhaps_RR the_AT conjunctiva_NN1 lymphoid_NN1 tissue_NN1 is_VBZ no_RR21 longer_RR22 able_JK to_TO fight_VVI off_II the_AT disease_NN1 ._. 
</s>
<s>
This_DD1 may_VM be_VBI because_CS the_AT MoisturLoc_NP1 is_VBZ inhibiting_VVG cytokines_NN2 (_( e.g._REX ,_, IL-1_MC1 ,_, IL-6_MC ,_, IL-12_MC ,_, or_CC TNF-a_NP1 )_) that_CST normally_RR promote_VV0 defensive_JJ cells_NN2 to_TO attack_VVI the_AT fungus_NN1 ._. 
</s>
<s>
In_II this_DD1 way_NN1 ,_, a_AT1 Fusarium_NN1 Keratitis_NN1 infection_NN1 would_VM proceed_VVI easier_RRR ._. 
</s>
